Cardlytics (NASDAQ:CDLX) CEO Sells $61,923.51 in Stock

Cardlytics, Inc. (NASDAQ:CDLX) CEO Amit Gupta sold 62,549 shares of Cardlytics stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $0.99, for a total transaction of $61,923.51. Following the completion of the sale, the chief executive officer owned 1,111,445 shares in the company, valued at $1,100,330.55. The trade was a 5.33% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Amit Gupta also recently made the following trade(s):

• On Thursday, April 2nd, Amit Gupta sold 54,225 shares of Cardlytics stock. The shares were sold at an average price of $1.04, for a total value of $56,394.00.
• On Wednesday, February 18th, Amit Gupta sold 45,159 shares of Cardlytics stock. The stock was sold at an average price of $0.93, for a total value of $41,997.87.
• On Tuesday, February 17th, Amit Gupta sold 52,049 shares of Cardlytics stock. The shares were sold at an average price of $0.90, for a total value of $46,844.10.
• On Monday, January 5th, Amit Gupta sold 5,807 shares of Cardlytics stock. The stock was sold at an average price of $1.17, for a total value of $6,794.19.

Cardlytics Stock Performance

NASDAQ CDLX opened at $1.13 on Friday. The company has a market cap of $62.23 million, a PE ratio of -0.58 and a beta of 0.91. Cardlytics, Inc. has a 12 month low of $0.66 and a 12 month high of $3.28. The stock has a 50 day moving average of $0.90 and a 200-day moving average of $1.34.

Cardlytics (NASDAQ:CDLX) last released its earnings results on Wednesday, March 4th. The company reported ($0.15) earnings per share for the quarter, missing the consensus estimate of ($0.07) by ($0.08). The firm had revenue of $56.10 million during the quarter, compared to the consensus estimate of $54.46 million. Cardlytics had a negative net margin of 44.36% and a negative return on equity of 370.98%. As a group, sell-side analysts predict that Cardlytics, Inc. will post -1.52 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Vanguard Personalized Indexing Management LLC bought a new stake in shares of Cardlytics during the third quarter valued at approximately $26,000. Global Retirement Partners LLC lifted its holdings in shares of Cardlytics by 67.3% in the 3rd quarter. Global Retirement Partners LLC now owns 34,800 shares of the company’s stock worth $85,000 after purchasing an additional 14,000 shares in the last quarter. Goldman Sachs Group Inc. lifted its holdings in shares of Cardlytics by 15.1% in the 4th quarter. Goldman Sachs Group Inc. now owns 109,001 shares of the company’s stock worth $125,000 after purchasing an additional 14,273 shares in the last quarter. Geode Capital Management LLC grew its position in Cardlytics by 3.3% in the 4th quarter. Geode Capital Management LLC now owns 654,472 shares of the company’s stock valued at $753,000 after purchasing an additional 20,908 shares during the period. Finally, Sand Hill Global Advisors LLC bought a new stake in Cardlytics during the 2nd quarter valued at $35,000. Institutional investors own 68.10% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have issued reports on the company. Bank of America reaffirmed an “underperform” rating on shares of Cardlytics in a report on Thursday, March 5th. Wall Street Zen raised shares of Cardlytics from a “sell” rating to a “hold” rating in a research report on Saturday. Evercore set a $1.00 target price on shares of Cardlytics in a research note on Friday, March 6th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Cardlytics in a report on Monday, December 29th. Two investment analysts have rated the stock with a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Reduce” and a consensus target price of $1.75.

Cardlytics Company Profile

Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.

At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.